Showing results (241-250 of 285) with videos related to

Sort By:
Pageof 29
Leukemia Research|March 30, 2013
Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: a multicenter, randomized control trial in southwest ChinaXi Zhang, Yunlong Li, Yanqi Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 10, 2026
Olverembatinib-Based Therapy in Patients With Transformed Chronic Myeloid Leukemia in Lymphoid Blast Phase or Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective StudyMei Bao, Jian Huang, Zongru Li, et al.
Biomarker Research|July 23, 2020
Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphomaQiong Li, Wei Zhang, Jiali Li, et al.
Iscience|July 21, 2025
BMSC exosomes deliver JKAP to restore Th17/Treg balance via AKT/ERK, alleviating rheumatoid arthritisFang-Tian Xu, Yu Ling, Hui-Xian Wei, et al.
Current Medical Science|July 4, 2021
High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell LymphomaQin Wen, Li Gao, Jing-Kang Xiong, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 15, 2020
Establishment of a low-tumorigenic MDCK cell line and study of differential molecular networksGui-Lan Ma, Zi-Lin Qiao, Dan He, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 15, 2025
Pristimerin Promotes Ubiquitination of HSPA8 and Activates the VAV1/ERK Pathway to Suppress TNBC ProliferationQin-Wen Liu, Qi-Ling Fan, Jia-Ying Chen, et al.
Current Medical Science|June 17, 2023
Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell TransplantationXu Tan, Xiao-Qi Wang, Cheng Zhang, et al.
Cancers|June 24, 2022
The Machine-Learning-Mediated Interface of Microbiome and Genetic Risk Stratification in Neuroblastoma Reveals Molecular Pathways Related to Patient SurvivalXin Li, Xiaoqi Wang, Ruihao Huang, et al.
Molecular Cancer|March 25, 2023
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironmentRuiwen Ruan, Li Li, Xuan Li, et al.
Pageof 29